STANDARDS COORDINATING BODY FOR GE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

JUSTIN BARCH

Phone

3019756822

Tax Period

2023-01-01 to 2023-12-31

STANDARDS COORDINATING BODY FOR GENE CELL AND REGENERATIVE MEDICINE, founded in 2016, is a small nonprofit in the Science & Technology sector that reported $624K in total revenue in fiscal year 2023. Revenue fell 22% from the prior year — a significant decline worth monitoring. Expenses of $756K exceeded revenue, resulting in a 21% operating deficit.

Mission

COORDINATE THE ACCELERATED ADVANCEMENT AND IMPROVED AWARENESS OF STANDARDS THAT ADDRESS TEH RAPIDLY EVOLVING NEEDS OF THE GLOBAL REGERNATIVE MEDICINE AND CELL-BASED DRUG DISCOVERY COMMUNITY AND FACILITATE THE AVIALABILTY OF LIFE-CHANGING FUNCTIONAL CURES.

Program Service Accomplishments

Program 1

Expenses: $474,835 Revenue: $582,123

THE SCB DIRECTLY BENEFITS THE SCIENTISTS AND ENGINEERS WHO HAVE DAY-TO-DAY RESPONSIBILITY FOR CREATING AND MANAGING SCALABLE AND REPRODUCIBLE PROCESSES, AS WELL AS THE ASSAYS NEEDED TO ENSURE...

THE SCB DIRECTLY BENEFITS THE SCIENTISTS AND ENGINEERS WHO HAVE DAY-TO-DAY RESPONSIBILITY FOR CREATING AND MANAGING SCALABLE AND REPRODUCIBLE PROCESSES, AS WELL AS THE ASSAYS NEEDED TO ENSURE INDISPUTABLE QUALITY THROUGH SCB HELMED PROJECTS, EXPERTISE KNOWLEDGE, NETWORKING EVENTS AND EDUCATIONAL WORKSHOPS, PROFEESIONALS CAN ACCESS AND SHARE THE TECHNIQUES AND BEST PRACTICES NEEDED FOR SAFE, EFFECTIVE AND CONSISTENT PRODUCTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $41,588

Program Service Revenue $582,123

Investment Income $0

Other Revenue $0

TOTAL REVENUE $623,711

Expense Breakdown

Grants Paid $0

Salaries & Benefits $495,711

Fundraising Expenses $45,926

Program Expenses $474,835

Other Expenses $260,141

TOTAL EXPENSES $755,852

Year-over-Year Comparison

	2023	2022	Change
Revenue	$623,711	$794,895	-0.2%
Expenses	$755,852	$896,571	-0.2%
Net Income	$-132,141	$-101,676	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$197,692

Total Directors

$316,584

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JUSTIN BARCH	Executive Dir.	40.00	Officer Director	$197,692	$0	$197,692
DAWN HENKE	SR SCENTIFIC PM	40.00	Director	$118,892	$0	$118,892
RICHARD MCFARLAND	President	1.00	Officer Director	$0	$0	$0
APRIL LYNCH	Secretary	1.00	Officer Director	$0	$0	$0
MIKE KELLY	Director	1.00	Director	$0	$0	$0
MICHAEL ORRICO	Treasurer	1.00	Officer Director	$0	$0	$0
JESSICA CARMEN	Vice President	1.00	Officer Director	$0	$0	$0
ELIZABETH S WOO	Director	1.00	Director	$0	$0	$0
MIKE LEHMICKE	Director	1.00	Director	$0	$0	$0
NAYNESH KAMANI	Director	1.00	Director	$0	$0	$0
YUTAKA YANAGITA	Director	1.00	Director	$0	$0	$0
JENNIFER MANTLE	Director	1.00	Director	$0	$0	$0
MICHAEL MENDICINO	Director	1.00	Director	$0	$0	$0
ERIC ROOS	Director	1.00	Director	$0	$0	$0
KRISHNENDU ROY	Director	1.00	Director	$0	$0	$0
MORRIE RUFFIN	Director	1.00	Director	$0	$0	$0
MITCH SIVILOTI	Director	1.00	Director	$0	$0	$0
JASON WERTHEIM	Director	1.00	Director	$0	$0	$0
JIWEN ZHANG	Director	1.00	Director	$0	$0	$0
CLAUDIA ZYLBERBERG	Director	1.00	Director	$0	$0	$0
KURT GUNTER	Director	0.00	Director	$0	$0	$0
SVEN KILI	Director	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$623,711	$755,852	$67,777	$-132,141
2022	$794,895	$896,571	$113,159	$-101,676
2021	$714,927	$986,620	$242,168	$-271,693
2020	$271,772	$840,279	$491,190	$-568,507
2019	$682,505	$904,263	$1,108,815	$-221,758
2018	$1,437,196	$647,586	$1,222,982	$789,610

STANDARDS COORDINATING BODY FOR GENE CELL AND REGENERATIVE MEDICINE